Finally, EVT 301 (RO4477478), a reversible MAO-B inhibitor was evaluated on four AD patients (MMSE score: not specified) in a dose-finding study, using [11C]deprenyl-D2 ([11C]DED) PET (See further, Figure 11) to assess MAO-B occupancy levels. Here, MAOB is linked to Alzheimer disease.